Evidence map›Paper›PMID 34433845›Full record

ArticleScientific reports2021

Benchmarking laboratory processes to characterise low-biomass respiratory microbiota.

Raiza Hasrat, Jolanda Kool, Wouter A A de Steenhuijsen Piters, Mei Ling J N Chu, Sjoerd Kuiling, James A Groot, Elske M van Logchem, Susana Fuentes, Eelco Franz, Debby Bogaert and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analysis of metagenomic data.Nature reviews. Methods primers · 2025
    Article
  7. Article
  8. Article
  9. Salivary polyreactive antibodies andThe European respiratory journal · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Raiza HasratDepartment of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3508 AB, Utrecht, The Netherlands.
Jolanda KoolCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
Wouter A A de Steenhuijsen PitersDepartment of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3508 AB, Utrecht, The Netherlands.
Mei Ling J N ChuDepartment of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3508 AB, Utrecht, The Netherlands.
Sjoerd KuilingCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
James A GrootCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
Elske M van LogchemCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
Susana FuentesCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
Eelco FranzCentre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands.
Debby Bogaert *Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, 3508 AB, Utrecht, The Netherlands.
Thijs Bosch *Centre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands. thijs.bosch@rivm.nl.
National Institute for Public Health and the Environment · NLWilhelmina Children's Hospital · NLUniversity Medical Center Utrecht · NL

Funding

Chief Scientist Office SCAF/16/03
6 · The paper itself

Abstract

The low biomass of respiratory samples makes it difficult to accurately characterise the microbial community composition. PCR conditions and contaminating microbial DNA can alter the biological profile. The objective of this study was to benchmark the currently available laboratory protocols to accurately analyse the microbial community of low biomass samples. To study the effect of PCR conditions on the microbial community profile, we amplified the 16S rRNA gene of respiratory samples using various bacterial loads and different number of PCR cycles. Libraries were purified by gel electrophoresis or AMPure XP and sequenced by V2 or V3 MiSeq reagent kits by Illumina sequencing. The positive control was diluted in different solvents. PCR conditions had no significant influence on the microbial community profile of low biomass samples. Purification methods and MiSeq reagent kits provided nearly similar microbiota profiles (paired Bray-Curtis dissimilarity median: 0.03 and 0.05, respectively). While profiles of positive controls were significantly influenced by the type of dilution solvent, the theoretical profile of the Zymo mock was most accurately analysed when the Zymo mock was diluted in elution buffer (difference compared to the theoretical Zymo mock: 21.6% for elution buffer, 29.2% for Milli-Q, and 79.6% for DNA/RNA shield). Microbiota profiles of DNA blanks formed a distinct cluster compared to low biomass samples, demonstrating that low biomass samples can accurately be distinguished from DNA blanks. In summary, to accurately characterise the microbial community composition we recommend 1. amplification of the obtained microbial DNA with 30 PCR cycles, 2. purifying amplicon pools by two consecutive AMPure XP steps and 3. sequence the pooled amplicons by V3 MiSeq reagent kit. The benchmarked standardized laboratory workflow presented here ensures comparability of results within and between low biomass microbiome studies.

Indexed as

MicrobiotaBenchmarkingBiomassHumansMetagenomicsPolymerase Chain ReactionReagent Kits, DiagnosticRespiratory MucosaRNA, Ribosomal, 16SSalivaReagent Kits, DiagnosticRNA, Ribosomal, 16S

Identifiers

PMID34433845
PMCPMC8387476
OpenAlexW3158120795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.